Rocket Lab (RKLB) is a publicly traded Industrials sector company. As of November 17, 2026, RKLB trades at $57.10 with a market cap of $41.41B and a P/E ratio of -268.98. RKLB moved -0.46% today. Year to date, RKLB is -24.52%; over the trailing twelve months it is +25.95%. Its 52-week range spans $14.71 to $151.00. Analyst consensus is strong buy with an average price target of $95.35. Rallies surfaces RKLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rocket Lab delays Neutron’s first launch; Piper Sandler cuts target to $58: Rocket Lab reported third-quarter revenue of $267.83 million, up 73% year on year, and a 12-cent-per-share loss, wider than expected. Neutron’s first launch has shifted to next year, and Piper Sandler cut its target price to $58 from $83.
| Metric | Value |
|---|---|
| Price | $57.10 |
| Market Cap | $41.41B |
| P/E Ratio | -268.98 |
| EPS | $-0.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $151.00 |
| 52-Week Low | $14.71 |
| Volume | 617.89K |
| Avg Volume | 0 |
| Revenue (TTM) | $769.15M |
| Net Income | $-165.46M |
| Gross Margin | 37.26% |
18 analysts cover RKLB: 0 strong buy, 15 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $95.35.